SCPHARMACEUTICALS INC. Operating Income
SCPHARMACEUTICALS INC. reported Operating Income of -$14.29 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-08-07
- SCPHARMACEUTICALS INC. operating income (loss) for the quarter ending 2025-06-30 was -$14.29M.
- SCPHARMACEUTICALS INC. operating income (loss) for the quarter ending 2025-03-31 was -$17.76M.
- SCPHARMACEUTICALS INC. operating income (loss) for the quarter ending 2024-12-31 was -$16.34M.
- SCPHARMACEUTICALS INC. operating income (loss) for the quarter ending 2024-09-30 was -$18.15M.
- SCPHARMACEUTICALS INC. operating income (loss) for fiscal 2024 was -$64.78M.
- SCPHARMACEUTICALS INC. operating income (loss) for fiscal 2023 was -$55.40M.
- SCPHARMACEUTICALS INC. operating income (loss) for fiscal 2022 was -$36.16M.
- SCPHARMACEUTICALS INC. operating income (loss) for fiscal 2021 was -$25.82M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$14.29M 10-Q · filed 2025-08-07 | -$32.05M 10-Q · filed 2025-08-07 | -$48.39M derived: sum of 3 quarters · filed 2025-08-07 | -$66.54M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | -$17.76M 10-Q · filed 2025-05-14 | -$34.10M derived: sum of 2 quarters · filed 2025-05-14 | -$52.25M derived: sum of 3 quarters · filed 2025-05-14 | -$66.68M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-12-31 | -$16.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$34.49M derived: sum of 2 quarters · filed 2025-03-19 | -$48.92M derived: sum of 3 quarters · filed 2025-08-07 | -$64.78M 10-K · filed 2025-03-19 |
| 2024-09-30 | -$18.15M 10-Q · filed 2024-11-13 | -$32.58M derived: sum of 2 quarters · filed 2025-08-07 | -$48.43M 10-Q · filed 2024-11-13 | -$63.69M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | -$14.43M 10-Q · filed 2025-08-07 | -$30.29M 10-Q · filed 2025-08-07 | -$45.54M derived: sum of 3 quarters · filed 2025-08-07 | -$60.38M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$15.86M 10-Q · filed 2025-05-14 | -$31.11M derived: sum of 2 quarters · filed 2025-05-14 | -$45.95M derived: sum of 3 quarters · filed 2025-05-14 | -$59.70M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$15.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$30.10M derived: sum of 2 quarters · filed 2025-03-19 | -$43.84M derived: sum of 3 quarters · filed 2025-03-19 | -$55.40M 10-K · filed 2025-03-19 |
| 2023-09-30 | -$14.84M 10-Q · filed 2024-11-13 | -$28.59M derived: sum of 2 quarters · filed 2024-11-13 | -$40.14M 10-Q · filed 2024-11-13 | -$49.64M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$13.75M 10-Q · filed 2024-08-14 | -$25.30M 10-Q · filed 2024-08-14 | -$34.80M derived: sum of 3 quarters · filed 2024-08-14 | -$44.80M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$11.55M 10-Q · filed 2024-05-14 | -$21.06M derived: sum of 2 quarters · filed 2024-05-14 | -$31.05M derived: sum of 3 quarters · filed 2024-05-14 | -$40.47M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$19.50M derived: sum of 2 quarters · filed 2024-03-13 | -$28.92M derived: sum of 3 quarters · filed 2024-03-13 | -$36.16M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$9.99M 10-Q · filed 2023-11-08 | -$19.42M derived: sum of 2 quarters · filed 2023-11-08 | -$26.66M 10-Q · filed 2023-11-08 | -$33.38M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$9.42M 10-Q · filed 2023-08-10 | -$16.66M 10-Q · filed 2023-08-10 | -$23.38M derived: sum of 3 quarters · filed 2023-08-10 | -$29.29M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$7.24M 10-Q · filed 2023-05-10 | -$13.96M derived: sum of 2 quarters · filed 2023-05-10 | -$19.87M derived: sum of 3 quarters · filed 2023-05-10 | -$26.32M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$12.63M derived: sum of 2 quarters · filed 2023-03-22 | -$19.08M derived: sum of 3 quarters · filed 2023-03-22 | -$25.82M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$5.91M 10-Q · filed 2022-11-09 | -$12.36M derived: sum of 2 quarters · filed 2022-11-09 | -$19.10M 10-Q · filed 2022-11-09 | -$26.27M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$6.46M 10-Q · filed 2022-08-09 | -$13.20M 10-Q · filed 2022-08-09 | -$20.37M derived: sum of 3 quarters · filed 2022-08-09 | -$28.80M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$6.74M 10-Q · filed 2022-05-16 | -$13.91M derived: sum of 2 quarters · filed 2022-05-16 | -$22.35M derived: sum of 3 quarters · filed 2022-05-16 | -$30.02M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$15.61M derived: sum of 2 quarters · filed 2022-03-22 | -$23.28M derived: sum of 3 quarters · filed 2022-03-22 | -$29.93M 10-K · filed 2022-03-22 |
| 2020-09-30 | -$8.44M 10-Q · filed 2021-11-09 | -$16.11M derived: sum of 2 quarters · filed 2021-11-09 | -$22.76M 10-Q · filed 2021-11-09 | -$33.20M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$7.68M 10-Q · filed 2021-08-11 | -$14.32M 10-Q · filed 2021-08-11 | -$24.76M derived: sum of 3 quarters · filed 2021-08-11 | -$31.05M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$6.65M 10-Q · filed 2021-05-12 | -$17.08M derived: sum of 2 quarters · filed 2021-05-12 | -$23.37M derived: sum of 3 quarters · filed 2021-05-12 | -$30.71M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$10.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$16.72M derived: sum of 2 quarters · filed 2021-03-23 | -$24.06M derived: sum of 3 quarters · filed 2021-03-23 | -$32.91M 10-K · filed 2021-03-23 |
| 2019-09-30 | -$6.29M 10-Q · filed 2020-11-16 | -$13.62M derived: sum of 2 quarters · filed 2020-11-16 | -$22.47M 10-Q · filed 2020-11-16 | -$27.69M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$7.33M 10-Q · filed 2020-08-13 | -$16.18M 10-Q · filed 2020-08-13 | -$21.41M derived: sum of 3 quarters · filed 2020-08-13 | -$27.25M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$8.85M 10-Q · filed 2020-05-12 | -$14.07M derived: sum of 2 quarters · filed 2020-05-12 | -$19.91M derived: sum of 3 quarters · filed 2020-05-12 | -$29.82M derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | -$5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | -$11.06M derived: sum of 2 quarters · filed 2020-03-24 | -$20.97M derived: sum of 3 quarters · filed 2020-03-24 | -$29.67M 10-K · filed 2020-03-24 |
| 2018-09-30 | -$5.84M 10-Q · filed 2019-11-12 | -$15.74M derived: sum of 2 quarters · filed 2019-11-12 | -$24.44M 10-Q · filed 2019-11-12 | -$31.15M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$9.90M 10-Q · filed 2019-08-07 | -$18.60M 10-Q · filed 2019-08-07 | -$25.31M derived: sum of 3 quarters · filed 2019-08-07 | -$30.56M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$8.70M 10-Q · filed 2019-05-08 | -$15.41M derived: sum of 2 quarters · filed 2019-05-08 | -$20.66M derived: sum of 3 quarters · filed 2019-05-08 | -$27.18M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | -$6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21 | -$11.96M derived: sum of 2 quarters · filed 2019-03-21 | -$18.48M derived: sum of 3 quarters · filed 2019-03-21 | -$23.44M 10-K · filed 2019-03-21 |
| 2017-09-30 | -$5.25M 10-Q · filed 2018-11-13 | -$11.77M derived: sum of 2 quarters · filed 2018-11-13 | -$16.73M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$6.52M 10-Q · filed 2018-08-14 | -$11.48M 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | -$4.96M 10-Q · filed 2018-05-07 | |||
| 2016-12-31 | -$17.91M 10-K · filed 2019-03-21 |